RETRACTED: Salidroside inhibits the growth, migration and invasion of Wilms' tumor cells through down-regulation of miR-891b
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference42 articles.
1. An unusual radiologic appearance of Wilms tumor;Drori;Urol Case Rep,2018
2. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition;Li;Am. J. Pathol.,2002
3. Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors;Stewenius;Clin. Cancer Res.,2007
4. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study;Tournade;J. Clin. Oncol.,2001
5. Review of phase I and II trials for Wilms' tumour - can we optimise the search for novel agents?;Brok;Eur. J. Cancer,2017
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dysregulation of non-coding RNAs in Wilms tumor;Pathology - Research and Practice;2023-06
2. Retraction notice to “Salidroside inhibits the growth, migration and invasion of Wilms' tumor cells through down-regulation of miR-891b” [Life Sci. 222 (2019) 60–68];Life Sciences;2022-09
3. Salidroside Affects Gut Microbiota Structure in db/db Mice by Affecting Insulin, Blood Glucose and Body Weight;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-08
4. Plant-microbial interaction: The mechanism and the application of microbial elicitor induced secondary metabolites biosynthesis in medicinal plants;Plant Physiology and Biochemistry;2021-10
5. Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR‑140‑5p/wnt5a/β‑catenin axis;Experimental and Therapeutic Medicine;2021-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3